New Delhi: Japan's largest drug maker Takeda Pharmaceuticals is looking to enter India for which the firm has started a study of the market that has been witnessing the high growth over the last few years.
"We are studying the possibility of entering into the Indian market and till now nothing has been finalised yet," Takeda Pharmaceuticals Spokesperson told a news agency from Tokyo over telephone.
Another Japanese company Daiichi Sankyo last year acquired majority stake in Ranbaxy Laboratories for over 22,000 crore.
Takeda said it is exploring all possibilities and has recently hired a US-based executive Shankar Suryanarayan to conduct research on the possibility of entering into the domestic market.
When asked whether the Japanese company is looking for acquisitions to enter the Indian market, he declined to comment saying, "Nothing has been finalised yet."
Takeda currently doesn't have the generic drug in its portfolio and is under pressure with Japanese government preferring non-branded products. Besides, Takeda's best selling anti-diabetic anti-diabetic medicine Actos will lose patent protection in 2011.
PTI
First Published: Wednesday, December 02, 2009, 19:07